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Abstract
Several recent papers have suggested that two-locus tests of association that incorporate gene ×
gene interaction can be more powerful than marginal, single-locus tests across a broad range of
multilocus interaction models, even after conservative correction for multiple testing. However,
because these two-locus tests are sensitive to marginal associations with either marker, they can
be difficult to interpret, and it is not immediately clear how to use them to select a list of the most
promising markers worthy of further study. Here we apply single- and two-locus tests to 29 single-
nucleotide polymorphisms (SNPs) selected from the dense marker map in the simulated Genetic
Analysis Workshop 15 data spanning several candidate regions (the HLA region, the four SNPs
flanking "Locus D," and two regions on the q-arm of chromosome 6). We compare the proposed
two-locus likelihood ratio tests (LRT) to Akaike and Bayesian Information Criteria (AIC and BIC)
for model selection, as well as AIC- and BIC-weighted measures of "SNP importance." The latter
provide summary measures of evidence for association between each SNP and disease – including
potential interactions with one or more other SNPs – by summing over all one- and two-SNP
models. Our results suggest that the LRT using conservative p-value criteria were sensitive (but not
specific) in identifying associated markers. Standard AIC and BIC criteria were similarly sensitive
but not specific. On the other hand, the AIC- and BIC-weighted importance measures yielded a
specific but not very sensitive rule for SNP selection. Algorithms incorporating gene × gene
interaction to prioritize markers for follow-up will require further development.
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Background
Like other complex diseases, the genetic components of
rheumatoid arthritis (RA) are challenging to study.
Although the association of RA with specific major histo-
compatibility complex class II DR loci (HLA-DRB1) alle-
les on chromosome 6 has been confirmed in numerous
populations [1], the exact mechanisms are still unknown.
Other susceptibility genes in the same region [2], and
other non-HLA genes [3], may play a role. Interactions
among loci may contribute broadly to the etiology of RA.
For some alleles, the association with RA may only exist
on a specific background of other alleles [2]. Therefore,
considering multiple loci simultaneously is sometimes
necessary for genetic studies of RA, as well as other com-
plex diseases.
Appropriate strategies to discover disease susceptibility
loci in the context of genetic association of complex dis-
ease involving large numbers of markers are still under
development. Marchini et al. [4] and Evans et al. [5] com-
pared standard single-locus tests to two-locus tests of the
null hypothesis that disease risk is constant across all com-
binations of genotypes at two loci (i.e., a test for main
effects at either locus or their joint gene × gene interac-
tion). They showed that, across a broad range of two-locus
penetrance models, screening all pairwise combinations
had comparable or greater power to detect a disease sus-
ceptibility locus than single-locus testing.
One drawback to using these two-locus tests is that null
single-nucleotide polymorphisms (SNPs) may "piggy-
back" on a causal SNP with a strong marginal effect
because the null hypothesis for the two-locus test assumes
neither SNP affects disease risk. Hence, it is not clear how
to interpret strongly significant results from two-locus
tests, especially in the context of selecting promising SNPs
and models to test in an independent data set.
We comprehensively screened 29 SNPs from the simu-
lated dense marker panel on chromosome 6 using both
single-marker and two-marker case-control association
tests. We considered traditional hypothesis testing (likeli-
hood-ratio tests of nested models) and two model selec-
tion/multi-model inference procedures: the Akaike
Information Criterion (AIC) and Bayesian Information
Criterion (BIC). The latter methods have potential advan-
tages: non-nested models can be easily ranked and meas-
ures of "SNP importance" can be constructed by
combining information across multiple models contain-
ing a SNP. We compare the performance of these
approaches by examining their abilities to identify the
most promising SNPs among our candidates.
Methods
All 100 replicates of the Genetic Analysis Workshop
(GAW15) simulated case-control data were used, each of
which included 1500 cases and 2000 controls. Each case
was randomly selected from one of the 1500 affected sib
pairs. We considered chromosome 6 both because it con-
tains two simulated causal genes (the DR locus and "locus
D" – we were unblinded to the simulated model), and
because dense genotyping data were available. Because an
exhaustive screen of all pairwise combinations of the
17,820 markers from the dense map on chromosome 6
proved too time-consuming using standard software
packages [e.g., SAS PROC LOGISTIC], we selected 29 can-
didate SNPs: 10 randomly-selected SNPs from the HLA
region (which contains the DR locus), 15 SNPs from two
candidate regions on 6q, and the four SNPs flanking the
locus D (see Table 1).
Five techniques (likelihood ratio test, AIC, BIC, weighted
AIC and weighted BIC) were used to screen these 29 mark-
ers for independent or joint association with risk of RA.
All SNPs were coded additively (Gi is the count of minor
alleles for marker i, ranging from 0 to 2). We fit single- and
two-locus models. For the single marker models, we cal-
Table 1: Candidate SNP markers
HLA Region r2 (DR)a Flanking Locus D q-arm
denseSNP6_3241b 0.608 denseSNP6_3915 denseSNP6_11568 denseSNP6_15916
denseSNP6_3426c 0.449 denseSNP6_3916 denseSNP6_11611 denseSNP6_11656
denseSNP6_3271 0.404 denseSNP6_3917 denseSNP6_11621 denseSNP6_15886
denseSNP6_3436c 0.030 denseSNP6_3918 denseSNP6_15881 denseSNP6_11596
denseSNP6_3281 0.020 denseSNP6_15976 denseSNP6_15961
denseSNP6_3236 0.006 denseSNP6_15921
denseSNP6_3261b 0.003 denseSNP6_16891
denseSNP6_3251 0.003 denseSNP6_11646
denseSNP6_3476c 0.001 denseSNP6_11666
denseSNP6_3201c 0.001 denseSNP6_11616
aThe diallelic r2 with DR C allele.
bMarginally significant at the study-wide level in over 50% of replicates.
cMarginally significant at the genome-wide level in over 50% of the replicates.BMC Proceedings 2007, 1(Suppl 1):S25 http://www.biomedcentral.com/1753-6561/1/S1/S25
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culated likelihood ratio tests (LRTs) by comparing the fit-
ted log-likelihood for the null logistic-regression model,
log odds = α,
to the fitted log-likelihood for "Model 1," containing the
single marker,
log odds = α + βi Gi.
This leads to a test statistic that has a 1 d.f. chi-square dis-
tribution under the null. For the two-marker models, the
LRT compares the null model to "Model 2," which
includes main effects for each marker and an interaction
term:
log odds = α + βi Gi + βj Gj + βij Gi Gj.
This test has 3 d.f. For every model, the AIC and BIC was
calculated as -2 ln(L) + 2p and -2 ln(L) + ln(n) p, respec-
tively, where L is the maximized value of the likelihood
function for the estimated model, p  is the number of
parameters in the model, and n (3500 for each model) is
the number of subjects the model used. Note that in order
to appropriately compare models, the LRT, AIC, and BIC
all require the same set of subjects be used for all models.
In particular, subjects missing any of the tested genotypes
should either be excluded from all analyses or missing
genotypes should be imputed. This was not an issue for
these analyses because there were no missing data in any
replicate.
The evidence in favor of a particular model M relative to
the null model can be summarized using the change in
AIC: ΔAICM = AICM-AIC0; ΔBICM is calculated in the same
way. By convention ΔAICM values smaller than -10 are
taken as strong evidence in favor of model M relative to
the null; values between -2 and 2 indicate the two models
are roughly equivalent; and values larger than 10 indicate
strong evidence against model M relative to the null [6].
These thresholds are motivated by the AIC and BIC
weights for each model:
where the sum in the denominator is over all models fit.
(BIC weights are formed similarly.) These weights can be
interpreted as posterior model probabilities under a uni-
form prior on the discrete set of 436 models considered
here [6,7]. (Hence, both ΔAICM and ΔBICM are roughly
proportional to the (log) Bayes factor comparing the two
models.) The importance of a given SNP can be measured
by summing the AIC (BIC) weights for the models con-
taining that SNP.
We fit all possible one- and two-SNP logistic regression
models and the null model, resulting in 29C2 + 29C1 + 1 =
436 candidate models. For the likelihood ratio test, we
consider two significance thresholds. "Genome-wide sig-
nificance" (p < 1.1 × 10-12) corresponds to a 0.05 thresh-
old Bonferroni-corrected for all single- and two-locus tests
from a genome-wide panel with roughly the same density
as the simulated dense chromosome 6 panel (300,000
markers). "Study-wide significance" corresponds to a 0.05
threshold Bonferroni-corrected for the 29 candidate SNPs
considered here (p < 0.05/435 = 1.1 × 10-4).
Results
Figure 1 shows the LRT, ΔAIC (ΔBIC) and AIC (BIC)
weights for each of the 435 non-null models over all 100
replicates. The models containing denseSNP6_3426 and
denseSNP6_3436 showed the largest LRT and -ΔAIC
(ΔBIC) (top two panels of Figure 1). Because the AIC
(BIC) for this model was several hundred units smaller
than the next smallest AIC (BIC), the AIC (BIC) weight
was ≈1, while the weights for all other models were ≈0
(<10-10) (bottom panel of Figure 1).
One hundred and eleven tests had 100% observed power
at the genome-wide significance level, including all 57
tests containing either denseSNP6_3426 or
denseSNP6_3436 (Figure 2); 137 tests had greater than
50% observed genome-wide power. The corresponding
figures for the study-wide significance level were 114 tests
(100% observed power) and 159 tests (>50% observed
power).
For every SNP, at least one of the models containing that
SNP had an LRT p-value less than 1.0 × 10-14, exceeding
the Bonferroni corrected thresholds for both study-wide
and genome-wide significance (Figure 3, top panel). Sim-
ilarly, the values of ΔAIC and ΔBIC were ≤10 for at least
one model containing that SNP (Figure 3, middle panel).
Thus, tests using standard (and quite conservative) signif-
icance thresholds were very non-specific. On the other
hand, the AIC and BIC importance measures were quite
specific: denseSNP6_3426 and denseSNP6_3436 uni-
formly had importance scores of ≈1, while all other SNPs
had importance scores ≈0 (Figure 3, bottom panel).
Discussion
Consistent with earlier general arguments [4,5], we found
that many two-locus tests for genetic association had per-
fect power to detect associations between RA and SNPs
near the DR locus in the GAW15 simulated data even after
very conservative genome-wide Bonferoni correction for
multiple comparisons. Further, the test that considered
AIC weight   =
−
− ∑
exp( . )
exp( . )
,
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M
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Log10 LRT, ΔAIC/ΔBIC, and AIC/BIC weights Figure 1
Log10 LRT, ΔAIC/ΔBIC, and AIC/BIC weights. Log10 LRT (top), ΔAIC, ΔBIC (middle), and AIC and BIC weights (bottom) 
for all 436 models over all 100 replicates, sorted alphabetically (by SNP1 and SNP2) from left to right of the x-axis (from left to 
right: the null model, the model with denseSNP6_11568 alone, the model with denseSNP6_11568 and denseSNP6_11596,..., 
the model with SNPs denseSNP6_3437 and denseSNP6_3476). Models containing either s3426 or s3436 are indicated by tick 
marks on the x-axis. The models containing denseSNP6_3426 and denseSNP6_3436 showed the largest LRT and -ΔAIC 
(ΔBIC). The dashed line in the top figure is the Bonferroni-corrected genome-wide significance threshold for a chi-squared test 
with 3 d.f., and the dotted line is the study-wide significance threshold.BMC Proceedings 2007, 1(Suppl 1):S25 http://www.biomedcentral.com/1753-6561/1/S1/S25
Page 5 of 7
(page number not for citation purposes)
SNPs denseSNP6_3426 and denseSNP6_3436 together
provided greater evidence for association (smaller p-val-
ues, smaller AIC and BIC values) than the tests consider-
ing either SNP alone. However, while powerful, these
two-locus tests were not very specific: every candidate SNP
– even those on the q arm of chromosome 6, which were
not in linkage disequilibrium with any of the simulated
causal variants – was significantly associated with risk of
RA at the genome-wide level when tested jointly with
either denseSNP6_3426 or denseSNP6_3436. This is
because the joint test can have good power even when
only one of the two SNPs affects disease risk. Similarly, the
change in AIC or BIC relative to the null model was not
very specific: every candidate SNP was included in at least
one model that had an AIC and BIC far smaller than that
of the null model. LRTs and AIC/BIC values may be useful
for ranking markers relative to each other (c.f. the middle
panel of Figure 3), but they may provide little guidance on
the absolute level of evidence for association (e.g., how
many SNPs are worth further investigation).
On the other hand, the AIC- and BIC-weighted impor-
tance measures were quite specific but not particularly
sensitive – only SNPs denseSNP6_3426 and
denseSNP6_3436 had non-negligible importance values,
although five of the ten HLA-region SNPs yielded signifi-
cance near the marginal genome-wide level and six
showed marginal study-wide significance in greater than
50% of the replicates (Table 1). This is because the AIC
and BIC model weights are calculated relative to the other
models considered; in this case, the evidence for model
denseSNP6_3426 and denseSNP6_3436 relative to every
other model was so strong its weight was ≈1. This suggests
an iterative process might be helpful in selecting SNPs for
further study: select those SNPs with importance above a
given threshold; remove them from the data set and recal-
culate SNP importance values (note that this does not
require any likelihoods to be recalculated); select any
SNPs whose importance exceeds the recalculated thresh-
old and repeat the selection process until no remaining
SNPs exceed the recalculated threshold.
Appropriate statistical strategies are currently being
sought for the consideration of statistical interactions that
may increase power, and are sometimes necessary, to
detect a causal variant. However, more work is needed to
develop sensitive and specific procedures for selecting
promising markers from a large-scale association study,
considering the great cost of genotyping large sample sizes
typical of second stage genome-wide association scans. In
the GAW15 simulated data (candidate SNPs from the
dense marker map on chromosome 6), we found that
naively applying conservative Bonferoni-corrected p-value
thresholds to the model-free two-locus test statistic pro-
posed by Marchini et al. yielded sensitive but not specific
tests of association. On the other hand, our proposed
straightforward application of AIC or BIC variable impor-
tance measures yielded a specific but not very sensitive
rule for SNP selection. These results are driven in large
part by the genetic architecture of the simulated RA trait.
The signal at the DR locus is strong enough and the sam-
ple size large enough to produce highly statistically signif-
icant results (p < 1 × 10-14) for loci in the HLA region even
when a null marker and its interactions are included in the
model; similarly, small differences in the linkage disequi-
librium structure between HLA markers and the DR locus
are amplified here so that a single pair of HLA markers
provided a far better fit than any other single marker or
pair of markers. The performance of these methods in
other situations – notably when the sample size is smaller
or the signal for association is much more modest, as is
expected for most complex disease loci – requires further
investigation.
In real situations, missing data can lead not only to a loss
of power, but may also make it impossible to compare
Observed power for LRT Figure 2
Observed power for LRT. Histogram of observed power 
(percent of replicates significant at genome-wide [top] or 
study-wide [bottom] level) for all 435 single- and two-locus 
tests.BMC Proceedings 2007, 1(Suppl 1):S25 http://www.biomedcentral.com/1753-6561/1/S1/S25
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Minimum LRT p-values, maximum -ΔAIC/-ΔBIC values and AIC/BIC importances for each SNP Figure 3
Minimum LRT p-values, maximum -ΔAIC/-ΔBIC values and AIC/BIC importances for each SNP. Minimum LRT 
p-values (top) and maximum -ΔAIC and -ΔBIC values (middle) over models containing a given SNP. Each point is the value for 
a given replicate. The bottom panel plots AIC and BIC importances for every SNP over all replicates. Note that for the top and 
bottom panels, no variation across replicates was observed (e.g., the minimum p-value over all tested models was <10-14 for 
every SNP).
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models with different SNPs, as we have described in our
Methods section. In these circumstances, we recommend
imputing missing SNPs using the local haplotype struc-
ture to create a complete data set prior to analysis, to
account for missing data problem while minimizing the
loss of information.
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